These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 77151)

  • 21. Antigenic studies on coronavirus. I. Identification of the structural antigens of human coronavirus, strain 229E.
    Yaseen SA; Johnson-Lussenburg CM
    Can J Microbiol; 1981 Mar; 27(3):334-42. PubMed ID: 6165449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the use of monoclonal antibodies to hemagglutinin and fusion glycoproteins of Newcastle disease virus for virus identification and strain differentiation purposes.
    Meulemans G; Gonze M; Carlier MC; Petit P; Burny A; Le Long
    Arch Virol; 1987; 92(1-2):55-62. PubMed ID: 2432855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenic variation in rabies virus strains.
    Sodja I
    Acta Virol; 1986 Jul; 30(4):309-19. PubMed ID: 2429535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Further study of the phenomenon of the loss by mammals of natural resistance to infection by the Newcastle disease virus].
    Chepulis GkS ; Zhdanov VM
    Vopr Virusol; 1973; 18(6):653-60. PubMed ID: 4208162
    [No Abstract]   [Full Text] [Related]  

  • 25. [Detection of cellular antigens in myxoviruses and paramyxoviruses by the immunodiffusion method].
    Chepulis GS; Zhdanov VM; Nas I; Cherba I; Rozha K
    Vopr Virusol; 1971; 16(1):62-70. PubMed ID: 4327858
    [No Abstract]   [Full Text] [Related]  

  • 26. Antigenic variation between Newcastle disease viruses of goose and chicken origin.
    Li ZJ; Li Y; Chang S; Ding Z; Mu LZ; Cong YL
    Arch Virol; 2010 Apr; 155(4):499-505. PubMed ID: 20204429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Infectivity of mumps virus to chicks and its relation to Newcastle disease virus].
    Cunha RG; Quintais AC; Barros LF
    Rev Bras Biol; 1980 Feb; 40(1):125-30. PubMed ID: 7403588
    [No Abstract]   [Full Text] [Related]  

  • 28. Structural features unique to each of the three antigenic sites on the hemagglutinin-neuraminidase protein of Newcastle disease virus.
    Gotoh B; Sakaguchi T; Nishikawa K; Inocencio NM; Hamaguchi M; Toyoda T; Nagai Y
    Virology; 1988 Mar; 163(1):174-82. PubMed ID: 2450424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variation within a neutralizing domain on the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus.
    Iorio RM; Borgman JB; Glickman RL; Bratt MA
    J Gen Virol; 1986 Jul; 67 ( Pt 7)():1393-403. PubMed ID: 2425048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterisation of an antigenically unusual virus responsible for two outbreaks of Newcastle disease in the Republic of Ireland in 1990.
    Alexander DJ; Campbell G; Manvell RJ; Collins MS; Parsons G; McNulty MS
    Vet Rec; 1992 Jan; 130(4):65-8. PubMed ID: 1532467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of neutralizing (SN) and hemagglutination inhibiting (HI) antibodies on the course of Newcastle disease infection in chickens].
    Borzemska WB
    Pol Arch Weter; 1972; 15(3):495-512. PubMed ID: 4662589
    [No Abstract]   [Full Text] [Related]  

  • 32. Monoclonal antibodies to the HN glycoprotein of Newcastle disease virus. Biological characterization and use for strain comparisons.
    Nishikawa K; Isomura S; Suzuki S; Watanabe E; Hamaguchi M; Yoshida T; Nagai Y
    Virology; 1983 Oct; 130(2):318-30. PubMed ID: 6196907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Observations on the antigenic relationships between Epstein-Barr virus and herpesvirus saimiri.
    Morgan DG
    J Gen Virol; 1977 Aug; 36(2):281-7. PubMed ID: 70507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibodies to three structural proteins of Newcastle disease virus: biological characterization with particular reference to the conformational change of envelope glycoproteins associated with proteolytic cleavage.
    Umino Y; Kohama T; Sato TA; Sugiura A; Klenk HD; Rott R
    J Gen Virol; 1990 May; 71 ( Pt 5)():1189-97. PubMed ID: 1693166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study of pigeons and chickens experimentally infected with PPMV-1 to determine antigenic relationships between PPMV-1 and NDV strains.
    Guo H; Liu X; Xu Y; Han Z; Shao Y; Kong X; Liu S
    Vet Microbiol; 2014 Jan; 168(1):88-97. PubMed ID: 24314393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection and differentiation of strains of Newcastle Disease Virus by complement fixation.
    Butterfield WK; Graves JH
    Avian Dis; 1975; 19(2):267-76. PubMed ID: 1156257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic and antigenic analysis of Newcastle disease viruses from recent outbreaks in Taiwan.
    Lin MY; Liu HJ; Ke GM
    Avian Pathol; 2003 Aug; 32(4):345-50. PubMed ID: 17585457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in the response of normal and transformed BHK21 cells to dual virus infection. Conditions affecting synergism between vesicular stomatitis virus and newcastle disease virus.
    Kisch AL; Gould I
    Virology; 1973 Nov; 56(1):1-11. PubMed ID: 4355526
    [No Abstract]   [Full Text] [Related]  

  • 39. Adequacy of commercial lentogenic vaccines against Canadian strains of viscerotropic Newcastle disease virus.
    Kaliannan K; Seawright GL; Derbyshire JB
    Can J Comp Med; 1975 Apr; 39(2):139-45. PubMed ID: 1125832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunity to Newcastle disease.
    Beard CW; Brugh M
    Am J Vet Res; 1975 Apr; 36(4 Pt 2):509-12. PubMed ID: 1092218
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.